
Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease which is characterized by chronic airflow limitation and a range of pathological changes in the lung, significant extra-pulmonary effects, and important comorbidities which may contribute to the severity of the disease in individual patients. COPD refers to a group of diseases that cause airflow blockage and breathing-related problems including emphysema, chronic bronchitis, and in some cases, asthma.
A Call for Case Studies in Managing COPD
AMGA, the American Medical Group Foundation (AMGF) and AMGA
Chairman’s Circle Member
Boehringer Ingelheim
are launching a research project which will compile evidence of best
practices in managing patients with COPD. We are seeking Case
Studies for inclusion in a Compendium of Best Practices.
The compendium will be made available to help other medical
organizations redesign care processes and practice patterns to better
serve the needs of patients with chronic lung disease.
Medical groups, IPA, academic practices and integrated delivery systems that have incorporated the management of COPD into their chronic care models are encouraged to submit a case study. We are most interested in population-wide efforts, but will also consider case studies from pilot programs that hold the promise of impacting larger populations of patients with COPD.
An expert panel of judges will review each case study and select those that merit publication as a Best Practice and have applicability to other health care provider organizations. Those selected to be included in the Compendium will receive $2,500 to help defray the cost of compiling their case studies. The judges will be looking for programs that have as their goals one or more of the following:
For more information download the Call for Case Studies for application guidelines.
If you have questions or need further information, contact Danielle Flowers at dflowers@amga.org or at (703) 838-0033, ext. 347.